Status and phase
Conditions
Treatments
About
The study of safety of ZIO-201-T in combination with doxorubicin in the treatment of advanced cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
30 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal